633 results on '"Pomerantz, Roger J."'
Search Results
2. HIV-1-Mediated Apoptosis of Neuronal Cells: Proximal Molecular Mechanisms of HIV-1-Induced Encephalopathy
3. Reply to Lagier et al
4. Approaching Eradication of Highly Active Antiretroviral Therapy-Persistent Human Immunodeficiency Virus Type 1 Reservoirs with Immune Activation Therapy
5. Reservoirs of Human Immunodeficiency Virus Type 1: The Main Obstacles to Viral Eradication
6. Recombinant Rabies Virus as Potential Live-Viral Vaccines for HIV-1
7. Amphipathic Domains in the C Terminus of the Transmembrane Protein (gp41) Permeabilize HIV-1 Virions: A Molecular Mechanism Underlying Natural Endogenous Reverse Transcription
8. A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection
9. Gene Therapy for HIV-1 Infection
10. Single Chain Variable Fragment-Based Strategies for Anti-HIV-1 Gene Therapy: Targeting the Viral Preintegration Complex and Combination Molecular Approaches
11. The Challenge of Finding a Cure for HIV Infection
12. Highly Attenuated Rabies Virus Based Vaccine Vectors Expressing Simian-Human Immunodeficiency $Virus_{89.6P}$ , Env and Simian Immunodeficiency $Virus_{mac239}$ Gag Are Safe in Rhesus Macaques and Protect from an AIDS-like Disease
13. Detection of HIV-1 Gene Sequences in Brain Tissues by in Situ Polymerase Chain Reaction
14. Attenuation of HIV-1 Infection by Other Microbial Agents
15. HIV-1 Infection and Genomics: Sorting out the Complexity
16. Intensification and Stimulation Therapy for Human Immunodeficiency Virus Type 1 Reservoirs in Infected Persons Receiving Virally Suppressive Highly Active Antiretroviral Therapy
17. Gene Therapy Using a Simian Virus 40-Derived Vector Inhibits the Development of in vivo Human Immunodeficiency Virus Type 1 Infection of Severe Combined Immunodeficiency Mice Implanted with Human Fetal Thymic and Liver Tissue
18. Human Immunodeficiency Virus Type 1-Infected Persons with Residual Disease and Virus Reservoirs on Suppressive Highly Active Antiretroviral Therapy Can Be Stratified into Relevant Virologic and Immunologic Subgroups
19. Reduced Mobilization of CD34⁺ Stem Cells in Advanced Human Immunodeficiency Virus Type 1 Disease
20. Potent Inhibition of Human Immunodeficiency Virus Type 1 Replication by an Intracellular Anti-Rev Single-Chain Antibody
21. CD14 is Involved in Control of Human Immunodeficiency Virus Type 1 Expression in Latently Infected Cells by Lipopolysaccharide
22. Blocked Early-Stage Latency in the Peripheral Blood Cells of Certain Individuals Infected with Human Immunodeficiency Virus Type 1
23. Chemokine Receptors and the Molecular Basis for Human Immunodeficiency Virus Type 1 Entry into Peripheral Hematopoietic Stem Cells and Their Progeny
24. Neurovirological Aspects of HIV Infection in the HAART Era
25. Isolation of a Second Recombinant Human Respiratory Syncytial Virus Monoclonal Antibody Fragment (Fab RSVF2-5) That Exhibits Therapeutic Efficacy in vivo
26. Human Herpesvirus 8 DNA Sequences in CD8⁺ T Cells [with Reply]
27. Human Herpesvirus Type 8 DNA Sequences in Cell-Free Plasma and Mononuclear Cells of Kaposi's Sarcoma Patients
28. Increased Human Immunodeficiency Virus Type 1 Replication in Human Peripheral Blood Mononuclear Cells Induced by Ethanol: Potential Immunopathogenic Mechanisms
29. T-cells and excitotoxicity: HIV-1 and other neurodegenerative disorders
30. Exogenous IL-7 induces Fas-mediated human neuronal apoptosis: potential effects during human immunodeficiency virus type 1 infection
31. Daily low-dose subcutaneous interleukin-2 added to single- or dual- nucleoside therapy in HIV infection does not protect against CD4 (super +) T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial
32. Central nervous system infections in individuals with HIV-1 infection
33. Lentiviral expression of HIV-1 Vpr induces apoptosis in human neurons
34. Treatment of Mycobacterium avium complex immune reconstitution disease in HIV-1-infected individuals
35. Twenty years of therapy for HIV-1 infection
36. Identification of an RNA element that confers post-transcriptional repression of connective tissue growth factor/hypertrophic chondrocyte specific 24 (ctgf/hcs24) gene: Similarities to retroviral RNA-protein interactions
37. Nuclear and nucleolar targeting of human ribosomal protein S25: Common features shared with HIV-1 regulatory proteins
38. Association of provider and patient characteristics with HIV-infected women's antiretroviral therapy regimen
39. SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial
40. A cis-acting peptide signal in human immunodeficiency virus type I Rev which inhibits nuclear entry of small proteins
41. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy
42. Molecular Diagnostic Techniques and Other Tests for Direct Detection of HIV
43. List of Contributors
44. Kynurenine pathway metabolism in human blood–brain–barrier cells: implications for immune tolerance & neurotoxicity
45. AIDS dementia and HIV-1-induced neurotoxicity: Possible pathogenic associations and mechanisms
46. Effects of Highly Active Antiretroviral Therapy on HIV-1-Associated Oral Complications
47. IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART
48. HIV-I gene therapy: Promise for the future
49. HIV-1 Vif versus APOBEC3G: newly appreciated warriors in the ancient battle between virus and host
50. SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.